Agios Pharmaceuticals, Inc. (LON:0HB0)
London flag London · Delayed Price · Currency is GBP · Price in USD
33.74
+0.66 (1.99%)
At close: Jun 27, 2025

Agios Pharmaceuticals Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1,4131,4979771,2801,3182,198
Upgrade
Market Cap Growth
-0.13%53.19%-23.69%-2.87%-40.02%-10.83%
Upgrade
Enterprise Value
4132193525043601,937
Upgrade
Last Close Price
24.4426.3217.5025.5124.9232.40
Upgrade
PE Ratio
2.742.78--1.11-
Upgrade
PS Ratio
49.3151.3546.40108.35--
Upgrade
PB Ratio
1.251.221.541.401.387.51
Upgrade
P/TBV Ratio
1.251.221.541.401.387.51
Upgrade
EV/Sales Ratio
15.307.5116.7042.61--
Upgrade
EV/FCF Ratio
-1.32-----
Upgrade
Debt / Equity Ratio
0.040.040.090.080.080.26
Upgrade
Asset Turnover
0.030.030.030.01--
Upgrade
Inventory Turnover
11.7713.0821.65---
Upgrade
Quick Ratio
17.1211.0611.4912.5417.176.07
Upgrade
Current Ratio
18.5011.9012.2713.3017.796.75
Upgrade
Return on Equity (ROE)
60.26%57.29%-36.83%-19.38%-42.15%-63.33%
Upgrade
Return on Assets (ROA)
-22.88%-20.47%-22.49%-18.17%-20.65%-24.08%
Upgrade
Return on Capital (ROIC)
-23.60%-21.45%-23.65%-18.88%-24.98%-33.35%
Upgrade
Earnings Yield
36.47%35.95%-28.29%-15.02%89.89%-10.91%
Upgrade
FCF Yield
-22.11%-20.89%-23.87%-20.38%-23.14%-10.16%
Upgrade
Buyback Yield / Dilution
-3.98%-4.02%-1.57%9.36%12.39%-15.01%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.